Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market

Description:

The value of the Non-Small Cell Lung Cancer (NSCLC) market is expected to increase significantly over the forecast period across the leading eight developed nations, from $5.1 billion in 2013 to $7.9 billion in 2020. This equates to a Compound Annual Growth Rate (CAGR) of 6.6%. Growth will be driven by novel therapies entering the squamous cell carcinoma market segment, which is currently lacking effective treatment, unlike the non-squamous market segment. – PowerPoint PPT presentation

Number of Views:20

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market


1
Non-Small Cell Lung Cancer Market to 2020 - New
Therapies to Enhance Treatment Segmentation and
Drive Growth in an Increasingly Competitive Market
Single User License - 4995 Site User
License - 9990 Corporate User License -
14985 Publication Date - Jul 2014 Pages -
143 To know more details, email to
debora_at_reportstack.com
2
Summary
  • The value of the Non-Small Cell Lung Cancer
    (NSCLC) market is expected to increase
    significantly over the forecast period across the
    leading eight developed nations, from 5.1
    billion in 2013 to 7.9 billion in 2020. This
    equates to a Compound Annual Growth Rate (CAGR)
    of 6.6. Growth will be driven by novel therapies
    entering the squamous cell carcinoma market
    segment, which is currently lacking effective
    treatment, unlike the non-squamous market
    segment.
  • The report focuses on the increasing
    differentiation between the three main NSCLC
    subtypes squamous cell, adenocarcinoma, and
    large cell carcinoma. Common genetic and
    molecular aberrations within these histologies
    are being extensively researched and targeted by
    novel therapeutics and so the treatment algorithm
    between histological subtypes is forecast to
    become more differentiated over the forecast
    period.

3
Scope
- A disease introduction, which defines the
disease and looks at symptoms, diagnosis and
treatment- Analysis of the NSCLC marketed
landscape, including a comparison of the efficacy
and safety of the most prominent brands, as well
as the unmet needs of NSCLC treatment- Detailed
analysis of the NSCLC pipeline, covering among
other parameters, drug distribution by Phase,
molecule type and mechanism of action. The NSCLC
clinical trial landscape is analyzed with
particular emphasis on failure rates across
different trial Phases, as well as the trends in
clinical trial size, duration and primary
endpoint. This section also includes profiles and
single product forecasts for the most promising
pipeline drugs.- An epidemiological forecast of
the major NSCLC markets, in which projected
values include total and treated populations
4
Key Benefits
- Understand the NSCLC pipeline and the clinical
needs that it is addressing, particularly the
ways in which histology affects treatment options
and where in the treatment algorithm new products
will be positioned, as well as where unmet needs
remain- Develop their knowledge of key products
that may enter the market before 2020. Detailed
profiles of these products are provided, with a
focus on their clinical trial performance, as
well as how they can be incorporated into the
NSCLC treatment plan and what competition they
face.- Identify patterns of growth in the NSCLC
market over the forecast period and understand
the underlying causes, as well as observing the
contributions made by each major market and/or
late-stage pipeline drug to this growth.
5
If you are interested...
Contact Debora White Email
debora_at_reportstack.com Ph1-888-789-6604 http/
/www.reportstack.com
About PowerShow.com